Interleukin-2 gene therapy (St Jude Children's Research Hospital)

N/A

Report date: 2023/10/26 16:02:03

Base Information

Drug NameInterleukin-2 gene therapy (St Jude Children's Research Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionInterleukin-2 stimulants
TargetsInterleukin-2
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSt. Jude Children'S Research HospitalNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesSt. Jude Children'S Research HospitalNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A